title: Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer.
authors: P M
authors: PM
authors: Putora
authors: G
authors: G
authors: Benz
authors: R
authors: R
authors: Rodriguez
authors: M
authors: M
authors: Brutsche
authors: M
authors: M
authors: Früh
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D017789:Granuloma, Pyogenic / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D014133:Tracheal Diseases / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors